Name: Exoskeleton Market by Component (Sensors, Actuators, Power Systems, Controllers, Software), Functionality (Assistive, Rehabilitative, Augmentative, Preventive), Type (Powered, Passive, Hybrid), Body Part (Lower, Upper, Full Body) - Global Forecast to 2030
Brand: MarketsandMarkets
SKU: SE5773
Price: 4950 USD
Availability: InStock

報告摘要

The exoskeleton market is estimated to be USD 0.56 billion in 2025 and is projected to reach USD 2.03 billion by 2030, registering a CAGR of 29.4% during the forecast period. Exoskeletons are important for improving mobility for people with physical impairment and reducing physical strain for industrial workers, leading to the integration of exoskeletons in healthcare and manufacturing. As the elderly population increases and patients at home for rehabilitation become more prevalent, the need for exoskeletons will only rise. As more technologies become available (AI, sensors, lightweight materials), exoskeleton products will function better, cheaper, and be more available. The process of product development and the growth of the exoskeleton market internationally will only be improved by continued investments by both the public and private sectors. “Powered exoskeleton segment to register the highest CAGR during the forecast period.” The market for powered exoskeletons is experiencing accelerated growth, fueled by significant funding activities that underscore rising investor confidence and commercialization potential. For instance, in December 2023, German Bionic, a developer of electrically powered exoskeletons, secured more than USD 16.3 million in an expanded Series A funding round. This funding is aimed at strengthening the company’s collaboration with its industrialization partner, Mubea, to scale production and improve deployment capabilities. In the same month, Verve Motion, a Cambridge-based startup specializing in robotic exosuits designed to enhance the physical capabilities of workers in demanding roles, successfully raised USD 20 million in a Series B funding round. These developments reflect a broader trend of strategic investments in powered exoskeleton technologies, positioning them as viable solutions for industrial automation, injury prevention, and workforce augmentation across various sectors. “Industrial vertical to register the second-highest CAGR during the forecast period.” The industrial sector is rapidly emerging as a significant adopter of exoskeleton technology, driven by the need to improve worker safety, reduce fatigue, and increase productivity in labor-intensive environments. Exoskeletons are particularly useful in industries such as manufacturing, warehousing, logistics, and assembly lines, where workers often perform repetitive lifting, bending, and overhead tasks. By supporting the lower back, shoulders, and legs, these wearable devices help reduce the risk of musculoskeletal injuries, one of the most common causes of lost workdays and rising occupational health costs. “Germany to dominate European exoskeleton market.” Germany represents one of the most advanced and mature markets for exoskeleton technology in Europe, driven by strong industrial demand, innovation in healthcare, and significant private investments. The country’s robust manufacturing and logistics sectors are actively adopting exoskeletons to improve workforce efficiency and reduce musculoskeletal injuries. German Bionic, a leading domestic developer, exemplifies this trend. In December 2023, the company raised over USD 16.3 million in an expanded Series A funding round to advance its product portfolio. Its exoskeletons, Apogee and Apogee+, are used in logistics, retail, and healthcare settings to assist with lifting, walking, and posture correction. These connected wearables are helping redefine workplace ergonomics across Germany’s key industries. • By Company Type: Tier 1 – 25%, Tier 2 – 40%, and Tier 3 – 35% • By Designation: C-level Executives – 30%, Directors – 28%, and Others – 42% • By Region: North America– 43%, Europe – 15%, Asia Pacific– 37%, and RoW- 05% Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), and Levitate Technologies, Inc. (US) are some of the key players in the exoskeleton market. The study includes an in-depth competitive analysis of these key players in the exoskeleton market, with their company profiles, recent developments, and key market strategies. Research Coverage This research report categorizes the exoskeleton market by component (hardware, software), type (powered, passive, hybrid), body part (lower extremities, upper extremities, full body), structure (rigid, soft), mobility (stationary, mobile), vertical (healthcare, defense, industrial, construction, other verticals), and region (North America, Europe, Asia Pacific, and RoW). The report's scope covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the exoskeleton market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies (contracts, partnerships, agreements, new product launches, mergers & acquisitions); and recent developments associated with the exoskeleton market. This report covers the competitive analysis of upcoming startups in the exoskeleton market ecosystem. Reasons to Buy This Report The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall exoskeleton market and its subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers: • Analysis of key drivers (Rising demand for robotic rehabilitation solutions from healthcare sector, Increased adoption in industrial and manufacturing sectors, Increased FDA approvals for medical exoskeletons), restraints (High cost of ownership), opportunities (Integration of exoskeletons with AI and IoT technologies, Increasing adoption of exoskeletons in military and defense sector), and challenges (Comfort and movement interference for workers, Power supply limitations and operational downtime) influencing the growth of the exoskeleton market • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the exoskeleton market • Market Development: Comprehensive information about lucrative markets – the report analyses the exoskeleton market across varied regions. • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the exoskeleton market • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Ekso Bionics (US), Ottobock (Germany), DIH Medical (Switzerland), Comau (Italy), Myomo Inc. (US), CYBERDYNE Inc. (Japan), Lifeward Ltd. (Israel), Hyundai Motor Group Robotics LAB. (South Korea), B-Temia (Canada), Rex Bionics Ltd. (New Zealand), ABLE Human Motion (Spain), Laevo Exoskeletons (Netherlands), German Bionic Systems GmbH (Germany), Levitate Technologies, Inc. (US), among others in the exoskeleton market.

目錄 Table of Contents

1 INTRODUCTION 24 1.1 STUDY OBJECTIVES 24 1.2 MARKET DEFINITION 24 1.3 STUDY SCOPE 25 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 25 1.3.2 YEARS CONSIDERED 25 1.3.3 INCLUSIONS AND EXCLUSIONS 26 1.4 CURRENCY CONSIDERED 26 1.5 UNITS CONSIDERED 26 1.6 LIMITATIONS 26 1.7 STAKEHOLDERS 27 1.8 SUMMARY OF CHANGES 27 2 RESEARCH METHODOLOGY 29 2.1 RESEARCH DATA 29 2.1.1 SECONDARY DATA 30 2.1.1.1 List of major secondary sources 30 2.1.1.2 Key data from secondary sources 30 2.1.2 PRIMARY DATA 31 2.1.2.1 Intended participants and key opinion leaders in primary interviews 31 2.1.2.2 List of major participants in primary interviews 31 2.1.2.3 Key data from primary sources 32 2.1.2.4 Breakdown of primary interviews 32 2.1.3 SECONDARY AND PRIMARY RESEARCH 33 2.1.3.1 Key industry insights 34 2.2 MARKET SIZE ESTIMATION 34 2.2.1 BOTTOM-UP APPROACH 36 2.2.1.1 Approach to arrive at market size using bottom-up analysis (demand side) 36 2.2.2 TOP-DOWN APPROACH 37 2.2.2.1 Approach to arrive at market size using top-down analysis (supply side) 37 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 38 2.4 RESEARCH ASSUMPTIONS 39 2.5 RESEARCH LIMITATIONS 39 2.6 RISK ASSESSMENT 39 3 EXECUTIVE SUMMARY 40 4 PREMIUM INSIGHTS 44 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN EXOSKELETON MARKET 44 4.2 EXOSKELETON MARKET IN NORTH AMERICA, BY COUNTRY AND VERTICAL 45 4.3 EXOSKELETON MARKET IN ASIA PACIFIC, BY VERTICAL 45 4.4 EXOSKELETON MARKET, BY COUNTRY 46 5 MARKET OVERVIEW 47 5.1 INTRODUCTION 47 5.2 MARKET DYNAMICS 47 5.2.1 DRIVERS 48 5.2.1.1 Rising demand for robotic rehabilitation solutions from healthcare sector 48 5.2.1.2 Increased adoption in industrial and manufacturing sectors 48 5.2.1.3 Increased FDA approvals for medical exoskeletons 49 5.2.2 RESTRAINTS 49 5.2.2.1 High cost of ownership 50 5.2.3 OPPORTUNITIES 50 5.2.3.1 Integration of exoskeletons with AI and IoT technologies 50 5.2.3.2 Increasing adoption of exoskeletons in military and defense sectors 51 5.2.4 CHALLENGES 51 5.2.4.1 Comfort and movement interference for workers 51 5.2.4.2 Power supply limitations and operational downtime 52 5.3 VALUE CHAIN ANALYSIS 52 5.4 ECOSYSTEM ANALYSIS 54 5.5 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 55 5.6 PRICING ANALYSIS 56 5.6.1 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024 57 5.6.2 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024 58 5.6.3 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022–2024 59 5.6.4 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022–2024 60 5.7 TECHNOLOGY ANALYSIS 61 5.7.1 KEY TECHNOLOGIES 61 5.7.1.1 Actuators and motors 61 5.7.1.2 Sensors and feedback systems 61 5.7.2 COMPLEMENTARY TECHNOLOGIES 62 5.7.2.1 IoT connectivity 62 5.7.2.2 AI and ML 62 5.7.3 ADJACENT TECHNOLOGIES 62 5.7.3.1 Artificial muscles 62 5.7.3.2 Physical therapy equipment 62 5.8 PORTER'S FIVE FORCES ANALYSIS 63 5.8.1 INTENSITY OF COMPETITIVE RIVALRY 64 5.8.2 BARGAINING POWER OF SUPPLIERS 64 5.8.3 BARGAINING POWER OF BUYERS 64 5.8.4 THREAT OF SUBSTITUTES 64 5.8.5 THREAT OF NEW ENTRANTS 64 5.9 KEY STAKEHOLDERS AND BUYING CRITERIA 65 5.9.1 KEY STAKEHOLDERS IN BUYING PROCESS 65 5.9.2 BUYING CRITERIA 66 5.10 CASE STUDY ANALYSIS 67 5.10.1 ENHANCING WORKER ERGONOMICS AND PRODUCTIVITY AT JOHN DEERE WITH COMAU’S MATE-XT WEARABLE EXOSKELETON 67 5.10.2 ENHANCING LOGISTICS OPERATIONS AND WORKER WELL-BEING AT FIEGE GROUP WITH GERMAN BIONIC AI-POWERED EXOSKELETON TECHNOLOGY 67 5.10.3 ENHANCING WORKER SAFETY AND PRODUCTIVITY IN TUNNEL CONSTRUCTION AT GRANITE CONSTRUCTION WITH LEVITATE TECHNOLOGIES EXOSKELETONS 68 5.10.4 REDUCING PHYSICAL STRAIN IN TRUCK MAINTENANCE AT MAN TRUCK & BUS WITH HELP OF SUITX TECHNOLOGY BY OTTOBOCK 68 5.10.5 FORD MOTOR COMPANY ENHANCES WORKER SAFETY AND REDUCES INJURIES WITH EKSO BIONICS EKSOVEST 68 5.11 INVESTMENT AND FUNDING SCENARIO 69 5.12 TRADE ANALYSIS, 2020–2024 69 5.12.1 IMPORT SCENARIO (HS CODE 9021) 69 5.12.2 EXPORT SCENARIO (HS CODE 9021) 70 5.13 PATENT ANALYSIS 72 5.14 KEY CONFERENCES AND EVENTS, 2025–2026 75 5.15 TARIFF AND REGULATORY LANDSCAPE 76 5.15.1 TARIFF ANALYSIS, 2024 76 5.15.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 5.15.3 STANDARDS 79 5.16 IMPACT OF AI ON EXOSKELETON MARKET 79 5.16.1 INTRODUCTION 79 5.16.2 AI-SPECIFIC USE CASES 80 5.17 2025 US TARIFF IMPACT ON EXOSKELETON MARKET 81 5.17.1 INTRODUCTION 81 5.17.2 KEY TARIFF RATES 81 5.17.3 PRICE IMPACT ANALYSIS 82 5.17.4 KEY IMPACTS ON VARIOUS COUNTRIES/REGIONS 83 5.17.4.1 US 83 5.17.4.2 Europe 84 5.17.4.3 Asia Pacific 84 5.17.5 END-USE INDUSTRY IMPACT 85 6 EXOSKELETON MARKET, BY MATERIAL 87 6.1 INTRODUCTION 87 6.2 CARBON FIBER 87 6.2.1 GROWING EMPHASIS ON LIGHTWEIGHT MATERIALS IN WEARABLE ROBOTICS TO DRIVE MARKET 87 6.3 METAL 88 6.3.1 HIGH STRUCTURAL STRENGTH AND LOAD-BEARING CAPACITY TO DRIVE DEMAND 88 6.4 STEEL ALLOYS 88 6.4.1 SUPERIOR DURABILITY IN HARSH WORK ENVIRONMENTS TO DRIVE MARKET 88 6.5 ALUMINUM 89 6.5.1 CORROSION RESISTANCE AND LIGHTWEIGHT DESIGN TO FUEL SEGMENT GROWTH 89 7 EXOSKELETON MARKET, BY STRUCTURE 90 7.1 INTRODUCTION 90 7.2 RIGID EXOSKELETONS 90 7.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET 90 7.3 SOFT EXOSKELETONS 90 7.3.1 INCREASING STARTUP FUNDING AND EXPANDING USE IN PERSONAL STRUCTURE TO DRIVE MARKET 90 8 EXOSKELETON MARKET, BY MOBILITY 92 8.1 INTRODUCTION 93 8.2 STATIONARY 94 8.2.1 RISING DEMAND FOR REHABILITATION THERAPIES TO DRIVE MARKET 94 8.3 MOBILE 95 8.3.1 RISING STARTUP FUNDING AND EXPANDING USE IN PERSONAL MOBILITY TO DRIVE MARKET 95 9 EXOSKELETON MARKET, BY BODY PART 96 9.1 INTRODUCTION 97 9.2 LOWER EXTREMITIES 98 9.2.1 RISING PREVALENCE OF SPINAL CORD INJURIES TO BOOST MARKET DEMAND 98 9.3 UPPER EXTREMITIES 99 9.3.1 ADVANCEMENTS IN PASSIVE AND LIGHTWEIGHT EXOSKELETONS TO DRIVE MARKET 99 9.4 FULL BODY 100 9.4.1 ADOPTION IN COMPLEX REHABILITATION PROGRAMS AND RISING USE IN HEAVY INDUSTRIAL APPLICATIONS TO FUEL DEMAND 100 10 EXOSKELETON MARKET, BY COMPONENT 101 10.1 INTRODUCTION 102 10.2 SENSORS 103 10.2.1 INTEGRATION OF AI AND ML TO BOOST DEMAND 103 10.2.2 GYROSCOPES 104 10.2.3 ACCELEROMETERS 104 10.2.4 TILT SENSORS 104 10.2.5 FORCE/TORQUE SENSORS 105 10.2.6 POSITION SENSORS 105 10.2.7 ELECTROMYOGRAPHY SENSORS 105 10.3 ACTUATORS 105 10.3.1 COMPATIBILITY WITH ADVANCED CONTROLLERS AND SENSORS FOR REAL-TIME MOTION COORDINATION TO DRIVE MARKET 105 10.4 POWER SOURCES 106 10.4.1 ADVANCEMENTS IN BATTERY TECHNOLOGIES TO BOOST MARKET 106 10.5 CONTROL SYSTEMS 106 10.5.1 ADVANCEMENTS IN ML AND REAL-TIME DATA PROCESSING TO DRIVE MARKET 106 10.6 OTHER COMPONENTS 107 11 EXOSKELETON MARKET, BY TYPE 108 11.1 INTRODUCTION 109 11.2 POWERED EXOSKELETON 110 11.2.1 RISING ADOPTION OF ROBOTIC ASSISTANCE IN REHABILITATION AND MOBILITY SUPPORT FOR PATIENTS TO FUEL MARKET GROWTH 110 11.2.2 POWERED EXOSKELETONS, BY TECHNOLOGY 112 11.2.2.1 Advancements in battery technology and energy-efficient actuators to fuel market growth 112 11.2.2.2 Electric 113 11.2.2.3 Pneumatic 114 11.2.2.4 Hydraulic 114 11.3 PASSIVE EXOSKELETON 114 11.3.1 INCREASING FOCUS ON WORKPLACE ERGONOMICS AND INJURY PREVENTION TO FUEL ADOPTION 114 12 EXOSKELETON MARKET, BY VERTICAL 117 12.1 INTRODUCTION 118 12.2 HEALTHCARE 119 12.2.1 RISING FDA CLEARANCE AND STARTUP FUNDING TO FUEL GROWTH OF MEDICAL EXOSKELETONS SEGMENT 119 12.2.2 REHABILITATION 124 12.2.3 DISABILITY ASSISTANCE 124 12.2.4 ELDERLY CARE 124 12.3 DEFENSE 125 12.3.1 INCREASING DEMAND FOR ENHANCED SOLDIER PERFORMANCE AND OPERATIONAL EFFICIENCY TO COMPLEMENT MARKET GROWTH 125 12.3.2 ENHANCED MOBILITY 129 12.3.3 INJURY PREVENTION 129 12.3.4 STEALTH AND TACTICAL OPERATIONS 130 12.4 INDUSTRIAL 130 12.4.1 INCREASED FOCUS ON WORKPLACE SAFETY AND COMPLIANCE TO DRIVE MARKET 130 12.4.2 HEAVY LIFTING 134 12.4.3 REPETITIVE TASK ASSISTANCE 134 12.4.4 POSTURAL SUPPORT 135 12.4.5 LOGISTICS 135 12.4.6 MATERIAL HANDLING 135 12.5 CONSTRUCTION 136 12.5.1 INCREASING FOCUS ON WORKER HEALTH TO FUEL ADOPTION OF EXOSKELETONS 136 12.5.2 LIFTING ASSISTANCE 140 12.5.3 ENHANCED PRODUCTIVITY AND EFFICIENCY 140 12.6 OTHER VERTICALS 141 13 EXOSKELETON MARKET, BY REGION 146 13.1 INTRODUCTION 147 13.2 NORTH AMERICA 148 13.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 149 13.2.2 US 150 13.2.2.1 Growing military focus on injury prevention and surge in startup funding to drive market 150 13.2.3 CANADA 151 13.2.3.1 Government contracts supporting defense applications to boost market 151 13.2.4 MEXICO 152 13.2.4.1 Strategic investments in hospital infrastructure to foster revenue growth 152 13.3 EUROPE 153 13.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 154 13.3.2 UK 155 13.3.2.1 Government support through defense innovation program to propel market 155 13.3.3 GERMANY 156 13.3.3.1 Presence of leading exoskeleton manufacturers and startups to complement revenue growth 156 13.3.4 FRANCE 157 13.3.4.1 Strong public and private investment in MedTech to boost market 157 13.3.5 ITALY 159 13.3.5.1 Strong collaboration between research institutes and industry to drive market 159 13.3.6 POLAND 160 13.3.6.1 Strategic partnerships with global exoskeleton providers to drive market 160 13.3.7 NORDICS 161 13.3.7.1 Academic and institutional R&D in robotics to drive market 161 13.3.8 REST OF EUROPE 162 13.4 ASIA PACIFIC 163 13.4.1 MACRO ECONOMIC OUTLOOK FOR ASIA PACIFIC 165 13.4.2 CHINA 166 13.4.2.1 Military investment in wearable robotics for logistics and mobility to boost market 166 13.4.3 JAPAN 167 13.4.3.1 Rapidly aging population and government support to create lucrative market growth opportunities 167 13.4.4 SOUTH KOREA 168 13.4.4.1 Advancements in lightweight, AI-integrated wearable robotics systems to drive market 168 13.4.5 INDIA 170 13.4.5.1 Military adoption for enhanced soldier endurance and injury prevention to boost market 170 13.4.6 AUSTRALIA 171 13.4.6.1 High healthcare spending to encourage adoption of advanced assistive technologies and boost demand 171 13.4.7 INDONESIA 172 13.4.7.1 High paraplegic population demanding affordable mobility rehabilitation solutions to drive market 172 13.4.8 MALAYSIA 173 13.4.8.1 Rising demand for rehabilitation devices that support patient mobility recovery to create growth opportunities 173 13.4.9 THAILAND 174 13.4.9.1 Government-backed research funding to boost exoskeleton technology development 174 13.4.10 VIETNAM 175 13.4.10.1 Increased research initiatives by domestic academic and medical institutions to drive market 175 13.4.11 REST OF ASIA PACIFIC 176 13.5 REST OF THE WORLD 177 13.5.1 MACROECONOMIC OUTLOOK FOR ROW 177 13.5.2 MIDDLE EAST 178 13.5.2.1 Bahrain 180 13.5.2.1.1 Growing adoption of smart transportation and home automation to drive demand 180 13.5.2.2 Kuwait 180 13.5.2.2.1 Focus on improving healthcare accessibility and patient outcomes to fuel market 180 13.5.2.3 Oman 180 13.5.2.3.1 Rising prevalence of neurological and musculoskeletal disorders to drive market 180 13.5.2.4 Qatar 181 13.5.2.4.1 Strategic focus on defense modernization and soldier performance to increase market demand 181 13.5.2.5 Saudi Arabia 181 13.5.2.5.1 Vision 2030 focus on healthcare innovation and technology adoption to fuel market 181 13.5.2.6 UAE 182 13.5.2.6.1 Investment in R&D of intelligent robotic systems to drive market 182 13.5.2.7 Rest of the Middle East 182 13.5.3 SOUTH AMERICA 182 13.5.3.1 Partnerships with global exoskeleton technology providers and manufacturers to support market 182 13.5.4 AFRICA 183 13.5.5 SOUTH AFRICA 185 13.5.5.1 Focus on improving worker safety in high-risk mining operations to drive market 185 13.5.6 OTHER AFRICAN COUNTRIES 185 14 COMPETITIVE LANDSCAPE 186 14.1 OVERVIEW 186 14.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, JANUARY 2022–FEBRUARY 2025 186 14.3 REVENUE ANALYSIS, 2019–2023 188 14.4 MARKET SHARE ANALYSIS, 2024 189 14.5 COMPANY VALUATION AND FINANCIAL METRICS, 2024 191 14.6 BRAND/PRODUCT COMPARISON 192 14.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 193 14.7.1 STARS 193 14.7.2 EMERGING LEADERS 193 14.7.3 PERVASIVE PLAYERS 193 14.7.4 PARTICIPANTS 193 14.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 195 14.7.5.1 Company footprint 195 14.7.5.2 Region footprint 196 14.7.5.3 Vertical footprint 197 14.7.5.4 Type footprint 198 14.7.5.5 Body part footprint 199 14.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 200 14.8.1 PROGRESSIVE COMPANIES 200 14.8.2 RESPONSIVE COMPANIES 200 14.8.3 DYNAMIC COMPANIES 200 14.8.4 STARTING BLOCKS 200 14.8.5 COMPETITIVE BENCHMARKING: KEY STARTUPS/SMES, 2024 202 14.8.5.1 Detailed list of startups/SMEs 202 14.8.5.2 Competitive benchmarking of key startups/SMEs 203 14.9 COMPETITIVE SCENARIO 204 14.9.1 PRODUCT LAUNCHES 204 14.9.2 DEALS 205 14.9.3 EXPANSIONS 206 14.9.4 OTHER DEVELOPMENTS 207 15 COMPANY PROFILES 208 15.1 KEY PLAYERS 208 15.1.1 EKSO BIONICS 208 15.1.1.1 Business overview 208 15.1.1.2 Products/Solutions/Services offered 209 15.1.1.3 Recent developments 210 15.1.1.3.1 Product launches 210 15.1.1.3.2 Deals 210 15.1.1.3.3 Other developments 211 15.1.1.4 MnM view 211 15.1.1.4.1 Key strengths/Right to win 211 15.1.1.4.2 Strategic choices 211 15.1.1.4.3 Weaknesses and competitive threats 211 15.1.2 OTTOBOCK 212 15.1.2.1 Business overview 212 15.1.2.2 Products/Solutions/Services offered 212 15.1.2.3 Recent developments 213 15.1.2.3.1 Product launches 213 15.1.2.4 MnM view 213 15.1.2.4.1 Key strengths/Right to win 213 15.1.2.4.2 Strategic choices 213 15.1.2.4.3 Weaknesses and competitive threats 213 15.1.3 DIH MEDICAL 214 15.1.3.1 Business overview 214 15.1.3.2 Products/Solutions/Services offered 215 15.1.3.3 Recent developments 216 15.1.3.3.1 Deals 216 15.1.3.4 MnM view 216 15.1.3.4.1 Key strengths/Right to win 216 15.1.3.4.2 Strategic choices 217 15.1.3.4.3 Weaknesses and competitive threats 217 15.1.4 COMAU 218 15.1.4.1 Business overview 218 15.1.4.2 Products/Solutions/Services offered 218 15.1.4.3 Recent developments 219 15.1.4.3.1 Product launches 219 15.1.4.4 MnM view 219 15.1.4.4.1 Key strengths/Right to win 219 15.1.4.4.2 Strategic choices 219 15.1.4.4.3 Weaknesses and competitive threats 220 15.1.5 MYOMO INC. 221 15.1.5.1 Business overview 221 15.1.5.2 Products/Solutions/Services offered 222 15.1.5.3 Recent developments 222 15.1.5.3.1 Product launches 222 15.1.5.3.2 Other developments 223 15.1.5.4 MnM view 223 15.1.5.4.1 Key strengths/Right to win 223 15.1.5.4.2 Strategic choices 223 15.1.5.4.3 Weaknesses and competitive threats 223 15.1.6 CYBERDYNE INC. 224 15.1.6.1 Business overview 224 15.1.6.2 Products/Solutions/Services offered 225 15.1.6.3 Recent developments 226 15.1.6.3.1 Expansions 226 15.1.7 LIFEWARD LTD. 227 15.1.7.1 Business overview 227 15.1.7.2 Products/Solutions/Services offered 228 15.1.7.3 Recent developments 229 15.1.7.3.1 Deals 229 15.1.8 HYUNDAI MOTOR GROUP ROBOTICS LAB. 230 15.1.8.1 Business overview 230 15.1.8.2 Products/Solutions/Services offered 230 15.1.8.3 Recent developments 231 15.1.8.3.1 Product launches 231 15.1.8.3.2 Deals 231 15.1.9 B-TEMIA 232 15.1.9.1 Business overview 232 15.1.9.2 Products/Solutions/Services offered 232 15.1.10 REX BIONICS LTD. 233 15.1.10.1 Business overview 233 15.1.10.2 Products/Solutions/Services offered 233 15.2 OTHER PLAYERS 234 15.2.1 ABLE HUMAN MOTION 234 15.2.2 LAEVO EXOSKELETONS 235 15.2.3 GERMAN BIONIC SYSTEMS GMBH 236 15.2.4 LEVITATE TECHNOLOGIES, INC. 237 15.2.5 FOURIER 238 15.2.6 TREXO ROBOTICS 239 15.2.7 WANDERCRAFT 240 15.2.8 AGADE 241 15.2.9 EUROPE TECHNOLOGIES 242 15.2.10 GOGOA.EU 243 15.2.11 ARCHELIS INC. 244 15.2.12 P&S MECHANICS CO., LTD. 245 15.2.13 RB3D 246 15.2.14 JAPET MEDICAL DEVICES 247 15.2.15 PROTESO S.R.L. 248 16 APPENDIX 249 16.1 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 251 16.2 CUSTOMIZATION OPTIONS 253 16.3 RELATED REPORTS 253 16.4 AUTHOR DETAILS 254

圖表清單 List of Tables & Figures

TABLE 1 EXOSKELETON MARKET: ROLE OF COMPANIES IN ECOSYSTEM 55 TABLE 2 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE (USD), 2024 57 TABLE 3 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024 (USD) 58 TABLE 4 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION (USD), 2022–2024 59 TABLE 5 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION (USD), 2022–2024 60 TABLE 6 EXOSKELETON MARKET: PORTER'S FIVE FORCES ANALYSIS 63 TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EXOSKELETONS FOR TOP THREE VERTICALS 65 TABLE 8 KEY BUYING CRITERIA FOR EXOSKELETONS FOR TOP THREE VERTICALS 66 TABLE 9 IMPORT SCENARIO FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 70 TABLE 10 EXPORT SCENARIO FOR HS CODE 9021-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 71 TABLE 11 EXOSKELETON MARKET: LIST OF MAJOR PATENTS, 2022–2024 72 TABLE 12 EXOSKELETON MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 75 TABLE 13 MFN TARIFF FOR HS CODE 9021-COMPLIANT PRODUCTS EXPORTED BY US, 2024 76 TABLE 14 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 15 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77 TABLE 16 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 17 ROW: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78 TABLE 18 US-ADJUSTED RECIPROCAL TARIFF RATES, 2024 (USD BILLION) 81 TABLE 19 EXPECTED CHANGE IN PRICES AND IMPACT ON END-USE MARKETS DUE TO TARIFF IMPACT 82 TABLE 20 EXOSKELETON MARKET, BY MOBILITY, 2021–2024 (USD MILLION) 93 TABLE 21 EXOSKELETON MARKET, BY MOBILITY, 2025–2030 (USD MILLION) 93 TABLE 22 STATIONARY: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 94 TABLE 23 STATIONARY: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 94 TABLE 24 MOBILE: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 95 TABLE 25 MOBILE: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 95 TABLE 26 EXOSKELETON MARKET, BY BODY PART, 2021–2024 (USD MILLION) 97 TABLE 27 EXOSKELETON MARKET, BY BODY PART, 2025–2030 (USD MILLION) 97 TABLE 28 LOWER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 98 TABLE 29 LOWER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 99 TABLE 30 UPPER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 99 TABLE 31 UPPER EXTREMITIES: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 100 TABLE 32 FULL BODY: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 100 TABLE 33 FULL BODY: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 100 TABLE 34 EXOSKELETON MARKET, BY COMPONENT, 2021–2024 (USD MILLION) 102 TABLE 35 EXOSKELETON MARKET, BY COMPONENT, 2025–2030 (USD MILLION) 103 TABLE 36 EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 109 TABLE 37 EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 109 TABLE 38 EXOSKELETON MARKET, BY TYPE, 2021–2024 (THOUSAND UNITS) 110 TABLE 39 EXOSKELETON MARKET, BY TYPE, 2025–2030 (THOUSAND UNITS) 110 TABLE 40 POWERED: EXOSKELETON MARKET, BY BODY PART, 2021–2024 (USD MILLION) 111 TABLE 41 POWERED: EXOSKELETON MARKET, BY BODY PART, 2025–2030 (USD MILLION) 111 TABLE 42 POWERED: EXOSKELETON MARKET, BY MOBILITY, 2021–2024 (USD MILLION) 111 TABLE 43 POWERED: EXOSKELETON MARKET, BY MOBILITY, 2025–2030 (USD MILLION) 111 TABLE 44 POWERED: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 112 TABLE 45 POWERED: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 112 TABLE 46 POWERED: EXOSKELETON MARKET, BY TECHNOLOGY, 2021–2024 (USD MILLION) 113 TABLE 47 POWERED: EXOSKELETON MARKET, BY TECHNOLOGY, 2025–2030 (USD MILLION) 113 TABLE 48 PASSIVE: EXOSKELETON MARKET, BY BODY PART, 2021–2024 (USD MILLION) 115 TABLE 49 PASSIVE: EXOSKELETON MARKET, BY BODY PART, 2025–2030 (USD MILLION) 115 TABLE 50 PASSIVE: EXOSKELETON MARKET, BY MOBILITY, 2021–2024 (USD MILLION) 115 TABLE 51 PASSIVE: EXOSKELETON MARKET, BY MOBILITY, 2025–2030 (USD MILLION) 115 TABLE 52 PASSIVE: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 116 TABLE 53 PASSIVE: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 116 TABLE 54 EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 118 TABLE 55 EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 119 TABLE 56 HEALTHCARE: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 120 TABLE 57 HEALTHCARE: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 120 TABLE 58 HEALTHCARE: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 120 TABLE 59 HEALTHCARE: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 120 TABLE 60 HEALTHCARE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021–2024 (USD MILLION) 121 TABLE 61 HEALTHCARE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025–2030 (USD MILLION) 121 TABLE 62 HEALTHCARE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021–2024 (USD MILLION) 121 TABLE 63 HEALTHCARE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025–2030 (USD MILLION) 122 TABLE 64 HEALTHCARE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021–2024 (USD MILLION) 122 TABLE 65 HEALTHCARE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025–2030 (USD MILLION) 123 TABLE 66 HEALTHCARE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021–2024 (USD MILLION) 123 TABLE 67 HEALTHCARE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025–2030 (USD MILLION) 123 TABLE 68 DEFENSE: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 125 TABLE 69 DEFENSE: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 125 TABLE 70 DEFENSE: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 126 TABLE 71 DEFENSE: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 126 TABLE 72 DEFENSE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021–2024 (USD MILLION) 126 TABLE 73 DEFENSE: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025–2030 (USD MILLION) 127 TABLE 74 DEFENSE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021–2024 (USD MILLION) 127 TABLE 75 DEFENSE: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025–2030 (USD MILLION) 127 TABLE 76 DEFENSE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021–2024 (USD THOUSAND) 128 TABLE 77 DEFENSE: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025–2030 (USD THOUSAND) 128 TABLE 78 DEFENSE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021–2024 (USD THOUSAND) 129 TABLE 79 DEFENSE: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025–2030 (USD THOUSAND) 129 TABLE 80 INDUSTRIAL: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 130 TABLE 81 INDUSTRIAL: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 131 TABLE 82 INDUSTRIAL: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 131 TABLE 83 INDUSTRIAL: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 131 TABLE 84 INDUSTRIAL: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021–2024 (USD MILLION) 131 TABLE 85 INDUSTRIAL: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025–2030 (USD MILLION) 132 TABLE 86 INDUSTRIAL: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021–2024 (USD MILLION) 132 TABLE 87 INDUSTRIAL: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025–2030 (USD MILLION) 132 TABLE 88 INDUSTRIAL: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021–2024 (USD MILLION) 133 TABLE 89 INDUSTRIAL: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025–2030 (USD MILLION) 133 TABLE 90 INDUSTRIAL: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021–2024 (USD MILLION) 134 TABLE 91 INDUSTRIAL: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025–2030 (USD MILLION) 134 TABLE 92 CONSTRUCTION: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 136 TABLE 93 CONSTRUCTION: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 136 TABLE 94 CONSTRUCTION: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 137 TABLE 95 CONSTRUCTION: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 137 TABLE 96 CONSTRUCTION: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021–2024 (USD MILLION) 137 TABLE 97 CONSTRUCTION: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025–2030 (USD MILLION) 137 TABLE 98 CONSTRUCTION: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021–2024 (USD MILLION) 138 TABLE 99 CONSTRUCTION: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025–2030 (USD MILLION) 138 TABLE 100 CONSTRUCTION: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021–2024 (USD MILLION) 139 TABLE 101 CONSTRUCTION: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025–2030 (USD MILLION) 139 TABLE 102 CONSTRUCTION: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021–2024 (USD THOUSAND) 140 TABLE 103 CONSTRUCTION: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025–2030 (USD THOUSAND) 140 TABLE 104 OTHER VERTICALS: EXOSKELETON MARKET, BY TYPE, 2021–2024 (USD MILLION) 141 TABLE 105 OTHER VERTICALS: EXOSKELETON MARKET, BY TYPE, 2025–2030 (USD MILLION) 141 TABLE 106 OTHER VERTICALS: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 142 TABLE 107 OTHER VERTICALS: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 142 TABLE 108 OTHER VERTICALS: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2021–2024 (USD MILLION) 142 TABLE 109 OTHER VERTICALS: EXOSKELETON MARKET, FOR NORTH AMERICA, BY COUNTRY, 2025–2030 (USD MILLION) 143 TABLE 110 OTHER VERTICALS: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2021–2024 (USD MILLION) 143 TABLE 111 OTHER VERTICALS: EXOSKELETON MARKET, FOR EUROPE, BY COUNTRY, 2025–2030 (USD MILLION) 143 TABLE 112 OTHER VERTICALS: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2021–2024 (USD THOUSAND) 144 TABLE 113 OTHER VERTICALS: EXOSKELETON MARKET, FOR ASIA PACIFIC, BY COUNTRY, 2025–2030 (USD THOUSAND) 144 TABLE 114 OTHER VERTICALS: EXOSKELETON MARKET, FOR ROW, BY REGION, 2021–2024 (USD THOUSAND) 145 TABLE 115 OTHER VERTICALS: EXOSKELETON MARKET, FOR ROW, BY REGION, 2025–2030 (USD THOUSAND) 145 TABLE 116 EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 147 TABLE 117 EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 147 TABLE 118 NORTH AMERICA: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 150 TABLE 119 NORTH AMERICA: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 150 TABLE 120 US: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 151 TABLE 121 US: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 151 TABLE 122 CANADA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 152 TABLE 123 CANADA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 152 TABLE 124 MEXICO: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 153 TABLE 125 MEXICO: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 153 TABLE 126 EUROPE: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 155 TABLE 127 EUROPE: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 155 TABLE 128 UK: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 156 TABLE 129 UK: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 156 TABLE 130 GERMANY: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 157 TABLE 131 GERMANY: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 157 TABLE 132 FRANCE: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 158 TABLE 133 FRANCE: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 158 TABLE 134 ITALY: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 159 TABLE 135 ITALY: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 160 TABLE 136 POLAND: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 160 TABLE 137 POLAND: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 161 TABLE 138 NORDICS: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 161 TABLE 139 NORDICS: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 162 TABLE 140 REST OF EUROPE: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 162 TABLE 141 REST OF EUROPE: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 163 TABLE 142 ASIA PACIFIC: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD MILLION) 165 TABLE 143 ASIA PACIFIC: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD MILLION) 166 TABLE 144 CHINA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 167 TABLE 145 CHINA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 167 TABLE 146 JAPAN: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 168 TABLE 147 JAPAN: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 168 TABLE 148 SOUTH KOREA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 169 TABLE 149 SOUTH KOREA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 169 TABLE 150 INDIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 170 TABLE 151 INDIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 171 TABLE 152 AUSTRALIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 171 TABLE 153 AUSTRALIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 172 TABLE 154 INDONESIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 172 TABLE 155 INDONESIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 173 TABLE 156 MALAYSIA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 173 TABLE 157 MALAYSIA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 174 TABLE 158 THAILAND: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 174 TABLE 159 THAILAND: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 175 TABLE 160 VIETNAM: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 175 TABLE 161 VIETNAM: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 176 TABLE 162 REST OF ASIA PACIFIC: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 176 TABLE 163 REST OF ASIA PACIFIC: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 177 TABLE 164 ROW: EXOSKELETON MARKET, BY REGION, 2021–2024 (USD MILLION) 177 TABLE 165 ROW: EXOSKELETON MARKET, BY REGION, 2025–2030 (USD MILLION) 178 TABLE 166 MIDDLE EAST: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD THOUSAND) 178 TABLE 167 MIDDLE EAST: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD THOUSAND) 179 TABLE 168 MIDDLE EAST: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 179 TABLE 169 MIDDLE EAST: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 179 TABLE 170 SOUTH AMERICA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD MILLION) 183 TABLE 171 SOUTH AMERICA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD MILLION) 183 TABLE 172 AFRICA: EXOSKELETON MARKET, BY COUNTRY, 2021–2024 (USD THOUSAND) 184 TABLE 173 AFRICA: EXOSKELETON MARKET, BY COUNTRY, 2025–2030 (USD THOUSAND) 184 TABLE 174 AFRICA: EXOSKELETON MARKET, BY VERTICAL, 2021–2024 (USD THOUSAND) 184 TABLE 175 AFRICA: EXOSKELETON MARKET, BY VERTICAL, 2025–2030 (USD THOUSAND) 185 TABLE 176 OVERVIEW OF STRATEGIES ADOPTED BY MAJOR COMPANIES, JANUARY 2022−FEBRUARY 2025 186 TABLE 177 EXOSKELETON MARKET: DEGREE OF COMPETITION, 2024 189 TABLE 178 EXOSKELETON MARKET: REGION FOOTPRINT 196 TABLE 179 EXOSKELETON MARKET: VERTICAL FOOTPRINT 197 TABLE 180 EXOSKELETON MARKET: TYPE FOOTPRINT 198 TABLE 181 EXOSKELETON MARKET: BODY PART FOOTPRINT 199 TABLE 182 EXOSKELETON MARKET: DETAILED LIST OF KEY STARTUPS/SMES 202 TABLE 183 EXOSKELETON MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 203 TABLE 184 EXOSKELETON MARKET: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2025 204 TABLE 185 EXOSKELETON MARKET: DEALS, JANUARY 2022– FEBRUARY 2025 205 TABLE 186 EXOSKELETON MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2025 206 TABLE 187 EXOSKELETON MARKET: OTHER DEVELOPMENTS, JANUARY 2022– FEBRUARY 2025 207 TABLE 188 EKSO BIONICS: COMPANY OVERVIEW 208 TABLE 189 EKSO BIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED 209 TABLE 190 EKSO BIONICS: PRODUCT LAUNCHES 210 TABLE 191 EKSO BIONICS: DEALS 210 TABLE 192 EKSO BIONICS: OTHER DEVELOPMENTS 211 TABLE 193 OTTOBOCK: COMPANY OVERVIEW 212 TABLE 194 OTTOBOCK: PRODUCTS/SOLUTIONS/SERVICES OFFERED 212 TABLE 195 OTTOBOCK: PRODUCT LAUNCHES 213 TABLE 196 DIH MEDICAL: COMPANY OVERVIEW 214 TABLE 197 DIH MEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED 215 TABLE 198 DIH MEDICAL: DEALS 216 TABLE 199 COMAU: COMPANY OVERVIEW 218 TABLE 200 COMAU: PRODUCTS/SOLUTIONS/SERVICES OFFERED 218 TABLE 201 COMAU: PRODUCT LAUNCHES 219 TABLE 202 MYOMO INC.: COMPANY OVERVIEW 221 TABLE 203 MYOMO INC..: PRODUCTS/SOLUTIONS/SERVICES OFFERED 222 TABLE 204 MYOMO INC.: PRODUCT LAUNCHES 222 TABLE 205 MYOMO INC.: OTHER DEVELOPMENTS 223 TABLE 206 CYBERDYNE INC.: COMPANY OVERVIEW 224 TABLE 207 CYBERDYNE INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 225 TABLE 208 CYBERDYNE INC.: EXPANSIONS 226 TABLE 209 LIFEWARD LTD.: COMPANY OVERVIEW 227 TABLE 210 LIFEWARD LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 228 TABLE 211 LIFEWARD LTD: DEALS 229 TABLE 212 HYUNDAI MOTOR GROUP ROBOTICS LAB.: COMPANY OVERVIEW 230 TABLE 213 HYUNDAI MOTOR GROUP ROBOTICS LAB.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 230 TABLE 214 HYUNDAI MOTOR GROUP ROBOTICS LAB.: PRODUCT LAUNCHES 231 TABLE 215 HYUNDAI MOTOR GROUP ROBOTICS LAB.: DEALS 231 TABLE 216 B-TEMIA: COMPANY OVERVIEW 232 TABLE 217 B-TEMIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED 232 TABLE 218 REX BIONICS LTD.: COMPANY OVERVIEW 233 TABLE 219 REX BIONICS LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED 233 TABLE 220 ABLE HUMAN MOTION: COMPANY OVERVIEW 234 TABLE 221 LAEVO EXOSKELETONS: COMPANY OVERVIEW 235 TABLE 222 GERMAN BIONIC SYSTEMS GMBH: COMPANY OVERVIEW 236 TABLE 223 LEVITATE TECHNOLOGIES, INC.: COMPANY OVERVIEW 237 TABLE 224 FOURIER: COMPANY OVERVIEW 238 TABLE 225 TREXO ROBOTICS: COMPANY OVERVIEW 239 TABLE 226 WANDERCRAFT: COMPANY OVERVIEW 240 TABLE 227 AGADE: COMPANY OVERVIEW 241 TABLE 228 EUROPE TECHNOLOGIES: COMPANY OVERVIEW 242 TABLE 229 GOGOA.EU: COMPANY OVERVIEW 243 TABLE 230 ARCHELIS INC.: COMPANY OVERVIEW 244 TABLE 231 P&S MECHANICS CO., LTD.: COMPANY OVERVIEW 245 TABLE 232 RB3D: COMPANY OVERVIEW 246 TABLE 233 JAPET MEDICAL DEVICES: COMPANY OVERVIEW 247 TABLE 234 PROTESO S.R.L.: COMPANY OVERVIEW 248 FIGURE 1 EXOSKELETON MARKET: RESEARCH DESIGN 29 FIGURE 2 MARKET SIZE ESTIMATION METHODOLOGY: SUPPLY-SIDE ANALYSIS 35 FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY-SIDE)—IDENTIFICATION OF REVENUE GENERATED BY COMPANIES FROM SALES OF EXOSKELETON DEVICES 35 FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 37 FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 38 FIGURE 6 EXOSKELETON MARKET BREAKDOWN AND DATA TRIANGULATION 38 FIGURE 7 POWERED TYPE TO LEAD EXOSKELETON MARKET DURING FORECAST PERIOD 41 FIGURE 8 LOWER EXTREMITIES SEGMENT TO CAPTURE LARGEST MARKET SHARE THROUGHOUT FORECAST PERIOD 41 FIGURE 9 HEALTHCARE VERTICAL TO LEAD EXOSKELETON MARKET DURING FORECAST PERIOD 42 FIGURE 10 EUROPE TO ACCOUNT FOR LARGEST SHARE OF EXOSKELETON MARKET IN 2025 43 FIGURE 11 RISING DEMAND FOR PHYSICAL REHABILITATION AND MOBILITY SUPPORT SOLUTIONS TO DRIVE MARKET GROWTH 44 FIGURE 12 US AND HEALTHCARE VERTICAL TO HOLD LARGEST SHARE OF NORTH AMERICAN EXOSKELETON MARKET IN 2025 45 FIGURE 13 HEALTHCARE VERTICAL TO ACCOUNT FOR LARGEST SHARE OF EXOSKELETON MARKET IN ASIA PACIFIC THROUGHOUT FORECAST PERIOD 45 FIGURE 14 EXOSKELETON MARKET IN JAPAN TO GROW AT HIGHEST CAGR FROM 2025 TO 2030 46 FIGURE 15 EXOSKELETON MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47 FIGURE 16 DRIVERS AND THEIR IMPACT ON EXOSKELETON MARKET 48 FIGURE 17 RESTRAINTS AND THEIR IMPACT ON EXOSKELETON MARKET 49 FIGURE 18 OPPORTUNITIES AND THEIR IMPACT ON EXOSKELETON MARKET 50 FIGURE 19 CHALLENGES AND THEIR IMPACT ON EXOSKELETON MARKET 51 FIGURE 20 EXOSKELETON MARKET: VALUE CHAIN ANALYSIS 53 FIGURE 21 EXOSKELETON MARKET: ECOSYSTEM ANALYSIS 54 FIGURE 22 EXOSKELETON MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 56 FIGURE 23 PRICING RANGE OF EXOSKELETON OFFERED BY KEY PLAYERS, BY TYPE, 2024 57 FIGURE 24 AVERAGE SELLING PRICE TREND OF EXOSKELETON, BY TYPE, 2022–2024 (USD) 58 FIGURE 25 AVERAGE SELLING PRICE TREND OF POWERED EXOSKELETON, BY REGION, 2022–2024 (USD) 59 FIGURE 26 AVERAGE SELLING PRICE TREND OF PASSIVE EXOSKELETON, BY REGION, 2022–2024 (USD) 60 FIGURE 27 PORTER'S FIVE FORCES ANALYSIS: EXOSKELETON MARKET 63 FIGURE 28 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR EXOSKELETONS FOR TOP THREE VERTICALS 65 FIGURE 29 KEY BUYING CRITERIA FOR EXOSKELETONS FOR TOP THREE VERTICALS 66 FIGURE 30 FUNDS ACQUIRED BY COMPANIES IN EXOSKELETON 69 FIGURE 31 IMPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS FOR TOP 5 COUNTRIES, 2020–2024 70 FIGURE 32 EXPORT DATA FOR HS CODE 9021-COMPLIANT PRODUCTS FOR TOP 5 COUNTRIES, 2020–2024 71 FIGURE 33 NUMBER OF PATENTS APPLIED AND GRANTED IN EXOSKELETON MARKET, 2014–2024 72 FIGURE 34 AI USE CASES 80 FIGURE 35 MOBILE SEGMENT TO HOLD LARGER SHARE OF EXOSKELETON MARKET IN 2030 93 FIGURE 36 LOWER EXTREMITIES BODY PART SEGMENT TO HOLD LARGEST SHARE OF EXOSKELETON MARKET IN 2030 97 FIGURE 37 ACTUATORS TO HOLD LARGEST SHARE OF EXOSKELETON MARKET IN 2030 102 FIGURE 38 POWERED EXOSKELETONS TO HOLD LARGER SHARE OF EXOSKELETON MARKET IN 2030 109 FIGURE 39 HEALTHCARE VERTICAL TO ACCOUNT FOR LARGEST MARKET SHARE DURING FORECAST PERIOD 118 FIGURE 40 EXOSKELETON MARKET: REGIONAL SNAPSHOT 147 FIGURE 41 NORTH AMERICA: EXOSKELETON MARKET SNAPSHOT 149 FIGURE 42 EUROPE: EXOSKELETON MARKET SNAPSHOT 154 FIGURE 43 ASIA PACIFIC: EXOSKELETON MARKET SNAPSHOT 164 FIGURE 44 REVENUE ANALYSIS OF KEY PLAYERS IN EXOSKELETON MARKET, 2019–2023 188 FIGURE 45 MARKET SHARE ANALYSIS OF MAJOR PLAYERS, 2024 189 FIGURE 46 COMPANY VALUATION, 2024 191 FIGURE 47 FINANCIAL METRICS (EV/EBITDA), 2024 191 FIGURE 48 EXOSKELETON MARKET: BRAND/PRODUCT COMPARISON 192 FIGURE 49 EXOSKELETON MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 194 FIGURE 50 EXOSKELETON MARKET: COMPANY FOOTPRINT 195 FIGURE 51 EXOSKELETON MARKET: COMPANY EVALUATION MATRIX (SMES/STARTUPS), 2024 201 FIGURE 52 EKSO BIONICS: COMPANY SNAPSHOT 209 FIGURE 53 DIH MEDICAL: COMPANY SNAPSHOT 215 FIGURE 54 MYOMO INC.: COMPANY SNAPSHOT 222 FIGURE 55 CYBERDYNE INC.: COMPANY SNAPSHOT 225 FIGURE 56 LIFEWARD LTD.: COMPANY SNAPSHOT 228

Single User Licence	$4,950 USD
Multi User Licence	$6,650 USD
Corporate User Licence	$8,150 USD
Global User Licence	$10,000 USD

Exoskeleton Market by Component (Sensors, Actuators, Power Systems, Controllers, Software), Functionality (Assistive, Rehabilitative, Augmentative, Preventive), Type (Powered, Passive, Hybrid), Body Part (Lower, Upper, Full Body) - Global Forecast to 2030

授權報價

報告摘要

同分類最新報告（電子與半導體）